Live feed
Filing
SC 13G/A
SC 13G/A0000902219-21-000062·Amneal Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Amneal Pharmaceuticals Inc
Security class unavailable · CUSIP: 03168L105
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 13,906,416
- Percent of class
- 9.4200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-21-000062
- Form type
- SC 13G/A
- Filer
- Amneal Pharmaceuticals, Inc.
- CIK
- CIK 1723128
- Filed
- Feb 03, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership